Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 5/20 | 0.42 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.41 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.41 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.41 |
| ▸ | NMT2 | O60551 | 1/20 | 0.41 |
| ▸ | NMT1 | P30419 | 1/20 | 0.41 |
| ▸ | NPY4R | P50391 | 8/20 | 0.39 |
| ▸ | NPY1R | P25929 | 6/20 | 0.39 |
| ▸ | NPY2R | P49146 | 5/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.39 |
| ▸ | FURIN | P09958 | 1/20 | 0.39 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.39 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2182536 | 1.00 | OPRK1 (0.42) | OPRK1ERAP2ERAP1LNPEPNMT2 | |
| SCHEMBL2193414 | 1.00 | OPRK1 (0.42) | OPRK1ERAP2ERAP1LNPEPNMT2 | |
| SCHEMBL2182039 | 1.00 | OPRK1 (0.42) | OPRK1ERAP2ERAP1LNPEPNMT2 | |
| SCHEMBL2195069 | 1.00 | OPRK1 (0.42) | OPRK1ERAP2ERAP1LNPEPNMT2 | |
| SCHEMBL2190396 | 0.95 | NPY4R (0.43) | OPRK1ERAP2ERAP1LNPEPNMT2 | |
| SCHEMBL2183569 | 0.93 | DPP8 (0.43) | OPRK1ERAP2ERAP1LNPEPNMT2 | |
| SCHEMBL2196706 | 0.93 | DPP8 (0.43) | OPRK1ERAP2ERAP1LNPEPNMT2 | |
| SCHEMBL2191184 | 0.93 | DPP8 (0.43) | OPRK1ERAP2ERAP1LNPEPNMT2 | |
| SCHEMBL1650994 | 0.91 | NMT2 (0.40) | OPRK1ERAP2ERAP1LNPEPNMT2 | |
| SCHEMBL28761909 | 0.90 | NPY4R (0.43) | OPRK1ERAP2ERAP1LNPEPNMT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166063-A1 | POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES | NEKTAR THERAPEUTICS (US) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166063-A1 | POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES | NGLY1, CD44, IAPP | OPRK1 2737/4885ERAP2 638/4885ERAP1 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.